VRDN logo

Viridian Therapeutics, Inc. (VRDN) Accounts payable

annual accounts payable:

$2.14M-$96.00K(-4.29%)
December 31, 2024

Summary

  • As of today (September 19, 2025), VRDN annual accounts payable is $2.14 million, with the most recent change of -$96.00 thousand (-4.29%) on December 31, 2024.
  • During the last 3 years, VRDN annual accounts payable has fallen by -$186.00 thousand (-7.99%).
  • VRDN annual accounts payable is now -84.94% below its all-time high of $14.23 million, reached on December 31, 2022.

Performance

VRDN Accounts payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherVRDNbalance sheet metrics

quarterly accounts payable:

$8.52M+$4.63M(+119.20%)
June 30, 2025

Summary

  • As of today (September 19, 2025), VRDN quarterly accounts payable is $8.52 million, with the most recent change of +$4.63 million (+119.20%) on June 30, 2025.
  • Over the past year, VRDN quarterly accounts payable has increased by +$5.38 million (+171.27%).
  • VRDN quarterly accounts payable is now -40.16% below its all-time high of $14.23 million, reached on December 31, 2022.

Performance

VRDN quarterly accounts payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherVRDNbalance sheet metrics

Accounts payable Formula

Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers

VRDN Accounts payable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-4.3%+171.3%
3 y3 years-8.0%+109.8%
5 y5 years+95.5%+2878.3%

VRDN Accounts payable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-84.9%at low-40.2%+297.5%
5 y5-year-84.9%+219.8%-40.2%+3571.6%
alltimeall time-84.9%+7926.2%-40.2%>+9999.0%

VRDN Accounts payable History

DateAnnualQuarterly
Jun 2025
-
$8.52M(+119.2%)
Mar 2025
-
$3.89M(+81.3%)
Dec 2024
$2.14M(-4.3%)
$2.14M(-66.2%)
Sep 2024
-
$6.34M(+101.8%)
Jun 2024
-
$3.14M(+17.3%)
Mar 2024
-
$2.68M(+19.5%)
Dec 2023
$2.24M(-84.3%)
$2.24M(-40.1%)
Sep 2023
-
$3.73M(-9.6%)
Jun 2023
-
$4.13M(-47.5%)
Mar 2023
-
$7.87M(-44.7%)
Dec 2022
$14.23M(+511.2%)
$14.23M(+250.5%)
Jun 2022
-
$4.06M(+60.0%)
Mar 2022
-
$2.54M(+9.0%)
Dec 2021
$2.33M(+247.6%)
$2.33M(-37.6%)
Sep 2021
-
$3.73M(+56.0%)
Jun 2021
-
$2.39M(-29.3%)
Mar 2021
-
$3.38M(+405.1%)
Dec 2020
$670.00K(-38.9%)
$670.00K(+188.8%)
Sep 2020
-
$232.00K(-18.9%)
Jun 2020
-
$286.00K(-82.4%)
Mar 2020
-
$1.63M(+48.6%)
Dec 2019
$1.10M
$1.10M(-29.6%)
Sep 2019
-
$1.56M(+26.3%)
DateAnnualQuarterly
Jun 2019
-
$1.23M(+138.3%)
Mar 2019
-
$517.00K(-9.5%)
Dec 2018
$571.00K(-37.0%)
$571.00K(-52.7%)
Sep 2018
-
$1.21M(+161.6%)
Jun 2018
-
$461.00K(-39.3%)
Mar 2018
-
$760.00K(-16.1%)
Dec 2017
$906.00K(+469.8%)
$906.00K(+121.5%)
Sep 2017
-
$409.00K(-35.3%)
Jun 2017
-
$632.00K(-43.8%)
Mar 2017
-
$1.13M(+11.7%)
Dec 2016
$159.00K(-34.3%)
$1.01M(+1874.5%)
Sep 2016
-
$51.00K(-45.7%)
Jun 2016
-
$94.00K(-7.8%)
Mar 2016
-
$102.00K(-57.9%)
Dec 2015
$242.00K(-5.1%)
$242.00K(+24.1%)
Sep 2015
-
$195.00K(-41.3%)
Jun 2015
-
$332.00K(-13.5%)
Mar 2015
-
$384.00K(+50.6%)
Dec 2014
$255.00K(+155.0%)
$255.00K(+6.9%)
Sep 2014
-
$238.50K(+42.2%)
Jun 2014
-
$167.70K(>+9900.0%)
Dec 2013
$100.00K(+274.5%)
$0.00(-100.0%)
Dec 2012
$26.70K
-
Dec 2012
-
$26.70K

FAQ

  • What is Viridian Therapeutics, Inc. annual accounts payable?
  • What is the all time high annual accounts payable for Viridian Therapeutics, Inc.?
  • What is Viridian Therapeutics, Inc. annual accounts payable year-on-year change?
  • What is Viridian Therapeutics, Inc. quarterly accounts payable?
  • What is the all time high quarterly accounts payable for Viridian Therapeutics, Inc.?
  • What is Viridian Therapeutics, Inc. quarterly accounts payable year-on-year change?

What is Viridian Therapeutics, Inc. annual accounts payable?

The current annual accounts payable of VRDN is $2.14M

What is the all time high annual accounts payable for Viridian Therapeutics, Inc.?

Viridian Therapeutics, Inc. all-time high annual accounts payable is $14.23M

What is Viridian Therapeutics, Inc. annual accounts payable year-on-year change?

Over the past year, VRDN annual accounts payable has changed by -$96.00K (-4.29%)

What is Viridian Therapeutics, Inc. quarterly accounts payable?

The current quarterly accounts payable of VRDN is $8.52M

What is the all time high quarterly accounts payable for Viridian Therapeutics, Inc.?

Viridian Therapeutics, Inc. all-time high quarterly accounts payable is $14.23M

What is Viridian Therapeutics, Inc. quarterly accounts payable year-on-year change?

Over the past year, VRDN quarterly accounts payable has changed by +$5.38M (+171.27%)
On this page